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a b s t r a c t
Prototype foamy virus encodes a transactivator called Bel1 that enhances viral gene transcription and is
essential for PFV replication. Nuclear localization of Bel1 has been reported to rely on two proximal basic
motifs R199H200 and R221R222R223 that likely function together as a bipartite nuclear localization signal. In
this study, we report that mutating R221R222R223, but not R199H200, relocates Bel1 from the nucleus to the
cytoplasm, suggesting an essential role for R221R222R223 in the nuclear localization of Bel1. Although not
affecting the nuclear localization of Bel1, mutating R199H200 disables Bel1 from transactivating PFV
promoters. Results of EMSA reveal that the R199H200 residues are vital for the binding of Bel1 to viral
promoter DNA. Moreover, mutating R199H200 in Bel1 impairs PFV replication to a much greater extent
than mutating R221R222R223. Collectively, our ﬁndings suggest that R199H200 directly participate in Bel1
binding to viral promoter DNA and are indispensible for Bel1 transactivation activity.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Foamy viruses (FVs) are also known as spumaretroviruses. They
comprise the Spumaretrovirinae in the retrovirus family. FVs are
found in primates including chimpanzees and humans who
acquired the infection from non-human primates (NHP), as well
as nonprimates including cats, cows and horses (Achong et al.,
1971; Broussard et al., 1997; Hatama et al., 2001; Heneine et al.,
1998; Herchenroder et al., 1994; Materniak et al., 2006; Tobaly-
Tapiero et al., 2000). Different from other retroviruses such as
human immunodeﬁciency virus (HIV) and human T-lymphotropic
virus (HTLV) (Cullen, 1991), FVs harbor an internal promoter (IP) in
addition to the conventional long terminal repeat (LTR) promoter
(Linial, 1999; Lochelt et al, 1993). The IP promoter is located in the
coding region for the Env protein. The LTR promoter directs the
expression of structural genes, gag, pol and env, while the IP
promoter controls the synthesis of accessory proteins Tas and Bet
(Bodem et al., 1998; Holzschu et al., 1998; Lochelt et al., 1994,
1993). Both promoters are highly activated by Tas protein that
binds to Tas response elements (TREs) (He et al., 1996; Kang et al.,
1998; Omoto et al., 2004; Tan et al., 2010).
The prototype foamy virus (PFV) Tas protein, also called Bel1, is
a 300-amino-acid nuclear protein that is essential for virus
replication (Lochelt et al., 1991). Mutagenesis studies of Bel1 have
revealed a central 120-amino-acid segment as the DNA binding
domain and C-terminal sequence as the activation domain (He
et al., 1996, 1993; Venkatesh and Chinnadurai, 1993; Venkatesh
et al., 1993). Like most typical DNA-binding transcriptional activa-
tors, both nuclear localization and multimerization are required
for the transactivation activity of Bel1 (Chang et al., 1995; Tan
et al., 2008).
Bel1 bears putative nuclear localization signal (NLS) in the
central highly basic region (Flugel, 1991; Venkatesh et al., 1991).
Early studies have shown that residues 211 to 225 and/or 209 to
226 are necessary and sufﬁcient for Bel1 nuclear localization (He
et al., 1993; Venkatesh and Chinnadurai, 1993; Venkatesh et al.,
1993). Later studies showed that another two basic amino acids
R199H200 also regulate Bel1 nuclear localization, which suggests
that Bel1 carries a bipartite NLS consisting of residues 199 to 200
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and residues 211 to 223 (Chang et al., 1995; Lee et al., 1994). In
support of their NLS function, Bel1 mutants M199a (R199H200-
V199D200), M199b (R199H200-G199P200), and M221 (R221R222R223-
T221I222G223) are unable to transactivate PFV LTR-directed chlor-
amphenicol acetyltransferase (CAT) expression (Lee et al., 1994).
In this report, we further investigated the function of Bel1 NLS
and found that residues R221R222R223, but not R199H200, are
essential for nuclear localization of Bel1. Importantly, mutating
R199H200 impairs Bel1 transactivation of PFV promoters as a result
of the loss of binding to either the LTR or IP DNA. Our results have
further deﬁned the NLS sequence in Bel1 and unraveled the new
role of R199H200 in the binding of Bel1 to viral DNA.
Results
R199H200 are dispensable for Bel1 nuclear localization
Previous studies have shown that residues R221R222R223 are
important for Bel1 nuclear localization (Chang et al., 1995; He
et al., 1993; Lee et al., 1994; Venkatesh and Chinnadurai, 1993;
Venkatesh et al., 1993). A role of R199H200 residues in this regard
was reported in a study using a fusion protein Bel1-β-gal (Chang
et al., 1995). To further deﬁne the amino acids essential for the
nuclear localization of Bel1, we inserted into the EGFP-GST fusion
protein the peptide fragment of Bel1 that encompass the amino
acid positions 1–300, 192–226 and 201–226 (Fig. 1A) and inves-
tigated their subcellular localization by performing indirect immu-
noﬂuorescence microscopy assay (IFA). We also generated two
mutations of this peptide sequence, named M221 that changed
R221R222R223 to T221I222G223 and M199 that altered R199H200 to
S199D200. The monopartite NLS of SV40 large T antigen and the
bipartite NLS (BiNLS) of Xenopus laevis nucleoplasmin were also
inserted into EGFP-GST as positive controls of nuclear localization.
As shown in Fig. 1B, similar to the activity of SV40-NLS and the
BiNLS, the wild type sequence of Bel1 (WT) enabled nuclear
localization of the fusion protein. The M221 mutant was detected
predominantly in the cytoplasm. In contrast, the M199 mutant was
only seen within the nucleus. To conﬁrm these results, we inserted
Bel1 sequences at amino acid positions 192–226 and 201–226
separately into the EGFP-GST vector and examined their subcel-
lular localization. Both 192–266 and 201–226 peptides have the
R221R222R223 residues, and the 201–226 peptide lacks the R199H200
residues. The results of Fig. 1B show that both (192–226)- and
(201–226)-containing EGFP-GST fusion proteins are nuclear. All
together, these data suggest that residues R221R222R223 of Bel1 are
essential for Bel1 nuclear localization, whereas R199H200 are
dispensable.
We next examined the subcellular distribution of native Bel1.
Wild type Bel1 and several mutants were inserted into pcDNA3.1
(-) vector for expression and their subcellular localizations were
determined by IFA using anti-Bel1 serum. As shown in Fig. 1C, the
M199 mutant and wild type Bel1 were strictly localized in the
nucleus in contrast to M221 that was detected predominantly in
the cytoplasm. These results further conﬁrm that residues
R199H200 are nonessential for Bel1 nuclear distribution.
Since our M199 (R199H200-S199D200) mutant differs from
M199a (R199H200-V199D200) and M199b (R199H200-G199P200) that
were utilized in other studies (Chang et al., 1995; Lee et al., 1994),
we regenerated the M199a and M199b mutants and expressed
them in HeLa cells. Results of IFA showed that both M199a and
M199b accumulated in the nucleus with little cytoplasm distribu-
tion (Fig. 2). Together, we conclude that the R199H200 amino acids
are not involved in the nuclear localization of Bel1.
Bel1 M199 mutant fails to transactivate PFV LTR and IP promoters
We next measured the effects of the M199 and M221 mutations
on the transactivation activity of Bel1. To this end, HEK293T cells were
cotransfected with PFV LTR or IP luciferase reporter plasmid and wild
type Bel1 or its mutants. The results of luciferase assay showed that
wild type Bel1 increased the activities of the PFV LTR and IP
promoters by 15-fold and 70-fold, respectively (Fig. 3A). The M221
mutant activated the LTR and IP promoters by 3-fold and 40-fold
(Fig. 3A). The reduced activation is likely a result of the cytoplasmic
localization of M221. Although the M199 mutant is predominantly
nuclear, it completely lost the ability to activate LTR or IP promoter
(Fig. 3A). We repeated these experiments in HeLa cells and similar
results were observed (Fig. 3B). We therefore conclude that the M199
mutant is unable to transactivate LTR or IP promoter transcription
despite its presence within the nucleus, whereas M221 mutant is still
able to transactivate to a signiﬁcant degree.
Residues R199H200, but not R221R222R223, are important for Bel1
binding to LTR and IP promoters
One possible cause for the loss of transactivation activity of
M199 mutant is the defect in binding to the LTR or IP promoter. To
test this, we performed electrophoretic mobility shift assay
(EMSA) with PFV LTR and IP probes as previous described (Regad
et al., 2001). We ﬁrst puriﬁed EGFP-Bel1-GST Bel1 WT and M221
mutant, incubated these recombinant proteins with PFV LTR and IP
DNA probes, and followed by electrophoresis to resolve the
protein/DNA complexes. The results showed direct association of
wild type Bel1 with either LTR or IP probes (Fig. 4A and B). This
complex was lost in the presence of unlabeled LTR (125 ) or IP
(125 ) probes (Fig. 4A and B), demonstrating the speciﬁcity of the
interaction. In contrast, the recombinant M199 mutant did not
bind to either LTR or IP probes (Fig. 4A and B). These puriﬁed
proteins used in EMSA were also examined by Coomassie blue
staining (Fig. 4C). These results suggest that R199H200 are essential
for Bel1 to bind to LTR and IP promoters.
Mutating the R199H200 residues in Bel1 ablate PFV replication
In order to test the importance of the R199H200 and R221R222R223
amino residues of Bel1 in the context of viral replication, we
generated two infectious PFV clones, PFV Bel1 M199 and PFV Bel1
M221 that bear mutations of R199H200 and R221R222R223 in Bel1,
respectively. HEK293T and HT1080 cells were transfected with PFV
DNA. pEGFP-N1 was cotransfected to monitor transfection efﬁ-
ciency. Forty-eight hours post-transfection, the amount of virus in
the supernatants and the transfected cells was analyzed by
infecting an indicator cell line PFVL. Within the transfected cells,
levels of viral Gag and Bel1 were signiﬁcantly lower for the M199
and M221 mutants as compared to the wild type PFV (Fig. 5A and
C). Consistent with this, virus production was severely impaired
for both mutants with a more dramatic reduction for M199
(Fig. 5B). It was also conﬁrmed by Western blotting with anti-
Gag and anti-Bel1 antibodies (Fig. 5A). Since the infection of PFV in
HT1080 cells is cell lytic, we were able to monitor cytopathogenic
effect for both the wild type and mutated PFV. We observed that
transfection with wild type PFV led to the formation of numerous
syncytium, whereas no syncytium was observed for M199 and
very few for M221 (Fig. 5D). These results demonstrate that
residues R199H200 of Bel1 are crucial for PFV production in both
HEK293T and HT1080 cells.
We next tested whether the exogenous wild type Bel1 can
rescue PFV Bel1 M199. HEK293T cells were cotransfected with PFV
Bel1 M199 DNA and increasing amounts of wild type Flag-Bel1
plasmid DNA. The expression of viral proteins was examined
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by Western blot assay using appropriate antibodies. As shown in
Fig. 6A, wild type Flag–Bel1 markedly increased the expression of
Gag, Bet and Bel1 (Fig. 6A lane 3–5). Although the production of
PFV Bel1 M199 was rescued by exogenous wild type Flag-Bel1, PFV
particles in the supernatants were noninfectious (Fig. 6B), because
of the inability of Bel1 M199 to activate viral gene expression
(Fig. 3).
Discussion
As a key regulator of viral gene expression, Bel1 contains
conventional NLS and is located in the nucleus to conduct its
function (Bodem et al., 1998; Keller et al., 1991; Venkatesh et al.,
1991). Previous studies have established the key role of
R221R222R223 in Bel1 nuclear localization, yet the signiﬁcance
Fig. 1. R199H200 are nonessential for Bel1 nuclear distribution. (A) Schematic illustration of pC3-EGFP-X-GST vector and the inserted amino acid sequences. Rectangle box
ﬁlled with green represents EGFP DNA; blank rectangle box represents GST DNA; black lines represent pEGFP-C3 vector DNA. The name of plasmid is underneath or on the
left. NLS: SV40 T antigen monopartite NLS; BiNLS: Xenopus laevis nucleoplasmin bipartite NLS; WT: Bel1 wild type; M199: Bel1 R199H200-S199D200 mutant; M221: Bel1
R221R222R223-T221I222G223 mutant; 192–226 and 201–226: truncated Bel1. Capitalized letters represent amino acid sequence; the number denotes the amino acid position in
Bel1 protein; asterisk indicates Bel1 amino acid. (B) HeLa cells were transfected with PEI and ﬁxed 24 h post-transfection. The subcellular localization of EGFP-GST fusion
proteins was visualized directly. Nuclei were stained with DAPI. Representative images are shown. (C) HeLa cells were transfected with pcDNA3.1(-) vector, 3.1-Bel1 WT, 3.1-
Bel1 M199, or 3.1-Bel1 M221. Subcellular localization of Bel1 was visualized by indirect immunoﬂuorescence using anti-Bel1 serum. Nuclei were stained with DAPI.
Representative images are shown.
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of R199H200 in this regard is controversial. In this report, in order to
deﬁne the amino acids sequences that are required for nuclear
localization of Bel1, we employed an enhanced green ﬂuorescent
protein-glutathione S transferase (EGFP-GST) system that has been
widely utilized in studying subcellular localization of a number of
proteins including retrovirus transactivators (Alefantis et al., 2003;
Cheng et al., 2001; Gu et al., 2011; Meertens et al., 2004; Tsuji
et al., 2007). The results of mutagenesis studies have shown that
residues R221R222R223 are essential for Bel1 nuclear localization. In
contrast, residues R199H200 are dispensable, which disagrees with
the results of two reports that suggest the importance of R199H200
in Bel1 nuclear localization (Chang et al., 1995; Lee et al., 1994). In
Chang's paper, they utilized bel1-lacZ chimeric constructs and
inserted Bel1 sequences into the linker region. Their data showed
that the NLS of Bel1 consists of two essential basic amino acid
motifs, residues 199–200 and residues 211–223, that function in
an interdependent manner as does that of X. laevis nucleoplasmin
NLS. In our study, we utilized the EGFP-GST fusion protein.
Although the discrepancy between our results and Chang's reports
might be due to the difference in the chimeric proteins that were
used, we further validated our ﬁndings by mutating the R199H200
amino acids in the context of native Bel1. Our results argue against
the involvement of these two basic residues in nuclear localization
of Bel1.
Classical NLS consists of either one (monopartite) or two
(bipartite) stretches of basic amino acids (Dingwall and Laskey,
1991; Kalderon et al., 1984a; Robbins et al., 1991). Monopartite
NLSs, such as the NLS of SV40 T antigen (126PKKKRKV132), are
made up of short stretches of basic residues (Kalderon et al.,
1984b; Smith et al., 1985), whereas bipartite NLSs, such as that of
X. laevis nucleoplasmin (155KRPAATKKAGQAKKKK170), consist of
two clusters of basic residues that are separated by 10 to 12 amino
acids (Dingwall et al., 1988; Lange et al., 2007). At present, it is
premature to determine which type of NLS the Bel1 NLS belongs
to, given the uncertainty of whether other amino acids in addition
to R221R222R223 also contribute to Bel1 subcellular distribution. It is
noted that the 201–226 region of Bel1 contains a number of basic
amino acids that remain to be tested for nuclear localization
function.
Previous studies of Bel1 have alluded to the involvement of
residues proximal to R199H200 in relation to binding to promoter
DNA (He et al., 1993; Lee et al., 1994; Venkatesh et al., 1993). For
example, the analysis of BREs suggests that the residues R197P198R199
may contribute to the DNA binding ability of Bel1 (He et al., 1996).
We now show that M199 (R199H200-S199D200) mutation abrogate
the ability of Bel1 to bind to LTR or IP promoter, whereas the M221
(R221R222R223-T221I222G223) mutation exhibits wild type binding
ability. These data explain why the Bel1 M199, although seen in the
nucleus, loses its ability to activate both LTR and IP promoters. Along
the same line, the PFV Bel1 M199 virus is unable to replicate because
Bel1 M199 loses the binding to LTR and IP promoter.
Bel1 is a sequence-speciﬁc DNA-binding protein, needs inter-
action with cellular protein(s) and localization in the nucleus to
activate viral gene expression (He et al., 1996; Keller et al., 1991;
Kido et al., 2003). We observed that the PFV Bel1 M221 virus is
relatively more infectious than PFV Bel1 M199. Furthermore, Bel1
M221 can activate the IP promoter more efﬁciently than the LTR
promoter. Previous reports showed that IP is more sensitive to the
activation by low level of Bel1 than the LTR promoter (He et al.,
1996; Kang et al., 1998; Lochelt et al., 1994; Mergia, 1994). This
difference allows the expression of accessory genes under the
control of IP prior to the expression of structural genes controlled
by the LTR promoter. We therefore suspect that the residual
amount of the M221 mutant in the nucleus may sufﬁce to activate
IP to a substantial level but not the LTR promoter. This explains the
residual infectiousness of the PFV Bel1 M221 mutant. In contrast,
Fig. 2. Mutating R199H200 does not affect Bel1 nuclear localization. HeLa cells were transfected with the plasmids M199a (Bel1 R199H200-V199D200 mutant) or M199b (Bel1
R199H200-G199P200 mutant) by PEI and ﬁxed 24 h post-transfection. The subcellular localization of EGFP-Bel1-GST fusion proteins was visualized directly. Nuclei were
stained with DAPI. Representative images are shown.
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the PFV Bel1 M199 mutant could not replicate, this is because Bel1
M199 has lost binding to the BRE sequence of LTR and IP. These
ﬁndings suggest that PFV replication strictly depends on Bel1
binding to DNA, whereas there may be pathways in additional to
NLS-dependent active nuclear import, such as nuclear envelope
breakdown in mitosis. A more complete understanding of Bel1
functions will require a detailed elucidation of the mechanism
controlling its nuclear entry.
Fig. 3. The Bel1 M199 mutant does not transactivate PFV LTR and IP promoters. HEK293T (3105) (A) or HeLa (1.5105) (B) cells were cotransfected with 0.1 mg PFV LTR or
IP luciferase reporter plasmid, 0.6 mg 3.1-Bel1 or its mutants. To normalized transfection efﬁciency, pCMV-β-gal was cotransfected. After 48 h, relative luciferase activities
were measured. Results shown are the average of three independent experiments. *Po0.05 (paired t test).
Fig. 4. Residues R199H200 are vital for Bel1 to bind to LTR and IP promoters. (A–B) EMSA was performed with puriﬁed protein EGFP-GST, EGFP-Bel1-GST Bel1 wild type or
mutants. Digitonin-labeled DNA sequences derived from PFV LTR.BRE (A) or IP.BRE (B) were used as the probes. (C) Coomassie blue staining of puriﬁed protein EGFP-GST,
EGFP-Bel1-GST Bel1 wild type or mutants.
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Materials and methods
Plasmids
To generate mammalian expression vector pC3-EGFP-X-GST, the
coding sequence of glutathione-S-transferase (GST) was ampliﬁed
from pGEX-6P-1 (Amersham Biosciences) and cloned into pEGFP-C3
(Clontech) using KpnI and BamHI. The coding sequence of SV40 T
antigen monopartite NLS, X. laevis nucleoplasmin bipartite NLS, Bel1
wild type or mutants were inserted into pC3-EGFP-X-GST. To generate
bacterial expression vector pGEX-6P-1-EGFP, enhanced green ﬂuores-
cent protein (EGFP) gene was ampliﬁed from pEGFP-N1 and inserted
into pGEX-6P-1 in frame with GST gene. PFV full-length infectious
clone pCHFV, which contains a modiﬁed version of the cytomegalo-
virus (CMV) immediate-early promoter in place of the U3 region of the
5’ long terminal repeat (LTR), was kindly provided by Maxine L. Linial
Fig. 5. Mutating R199H200 in Bel1 abrogates PFV production. (A) HEK293T cells were transfected with wild type PFV DNA or Bel1-mutated forms. pEGFP-N1 was cotransfected
to monitor toxicity and transfection efﬁciency. After 48 h, whole cell lysates were subjected to Western blotting and probed with anti-Gag, anti-Bel1, anti-β-actin, and anti-
EGFP antibodies. Representative results from three independent experiments are shown. (B) Virus titer in supernatants (PFVL-Supernatants) and HEK293T cells (PFVL-Co-
culture) was measured by infecting PFVL. At 48 h post-infection, luciferase assay was performed using PFVL cells. Results shown are the average of three independent
experiments. (C) HT1080 cells were transfected with wild type or Bel1 mutated PFV infectious clones. pEGFP-N1 was cotransfected to monitor toxicity and transfection
efﬁciency. At 72 h post-transfection, Western blotting were performed with indicated antibodies. (D) The Gag proteins of PFV were visualized by indirect immuno-
ﬂuorescence using anti-Gag serum. Cellular nuclei were stained with 0.2 μg/ml DAPI. The syncytium in HT1080 cells was directly observed with Olympus IX71 microscope.
Arrowheads indicate the syncytium. Representative images are shown.
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(Life et al., 2008). Bel1 mutants (M199, M199a, M199b and M221), PFV
Bel1 M199, and PFV Bel1 M221 were generated using a QuikChange™
site-directed mutagenesis kit (Stratagene) with the following primers:
M199 sense 5′-AAAACCAAGACCTAGTGACGATCCTGTCCTTCGAT-
3′,
M199 antisense 5′-ATCGAAGGACAGGATCGTCACTAGGTCTTGGT
TTT-3′;
M199a sense 5′-AAAACCAAGACCTGTTGACGATCCTGTCCTTCGAT-3′,
M199a antisense 5′-ATCGAAGGACAGGATCGTCAACAGGTCTTGG
TTTT-3′;
M199b sense 5′-AAAACCAAGACCTGGGCCCGATCCTGTCCTTC-
GAT-3′,
M199b antisense 5′-ATCGAAGGACAGGATCGGGCCCAGGTCTTGG
TTTT-3′;
M221 sense 5′-CAGAAACGACCCACGATAGGATCCATCGATAAT-
GAG-3′,
M221 antisense 5′-CTCATTATCGATGGATCCTATCGTGGGTCGTTT
CTG-3′.
All the new constructs were conﬁrmed by DNA sequencing.
Cell culture and transfection
HeLa, HEK293T, HT1080, and PFV indicator cell line (PFVL) cells
were grown in Dulbecco's modiﬁed Eagle's medium (DMEM, high
glucose) (GIBCO) supplemented with 10% fetal bovine serum (FBS)
and antibiotics. Cells were maintained in a humidiﬁed atmosphere
containing 5% CO2 at 37 1C. The indicator cell line PFVL, stablely
expressing the ﬁreﬂy luciferase gene driven by PFV LTR, was
described previously (Xu et al., 2011). HeLa, HEK293T, and
HT1080 cells were transfected by polyethylenimines (PEI) (Poly-
sciences) in accordance with the manufacturer's instructions.
Antibodies and reagents
Anti-EGFP, anti-β-actin, and horseradish peroxidase-conjugated
anti-mouse secondary antibodies were purchased from Santa Cruz
Biotechnology. Anti-Bel1 and anti-Gag antibodies were generated
by immunizing mice with the corresponding full-length proteins
puriﬁed form Escherichia coli BL21 (DE3). 4′,6-diamidino-2-
phenylindole (DAPI) was purchased from Sigma. Fluorescein-
conjugated anti-mouse secondary antibodies were purchased from
Jackson ImmunoResearch Laboratories.
Immunoﬂuorescence microscopy assay (IFA)
The immunoﬂuorescence microscopy assay (IFA) was per-
formed as previously described (Liu et al., 2013) with some
modiﬁcations. HeLa cells were seeded on glass coverslips
in 12-well cell culture plates. Following wash in ice-cold
1phosphate-buffered saline (PBS), cells were ﬁxed with 4%
paraformaldehyde in PBS for 10 min at 4 1C, then permeabilized
with 0.2% Triton X-100 in PBS for 10 min at 4 1C. After incubation
in 1 ml blocking buffer containing 3% BSA at 4 1C for 2 h, cells were
incubated with anti-Bel1 or anti-Gag serums at 4 1C for another
2 h. After washing with 0.1% Triton X-100 in PBS four times for
5 min at room temperature, ﬂuorescein isothiocyanate (FITC)-
conjugated goat anti-mouse secondary antibodies were added at
4 1C for 1 h. Cellular nuclei were stained with 0.2 μg/ml DAPI for
10 min at room temperature (RT). Coverslips were then mounted
with 90% glycerol in PBS containing 1 mg/ml p-phenylenediamine
and observed with Olympus IX71 ﬂuorescence microscope.
Luciferase assay
HeLa or HEK293T cells were seeded in 12-well cell culture
plates one day before transfection. Cells were transfected with the
following DNA constructs: PFV pLTR-Luc or pIP-Luc, pcDNA3.1
(-)-Bel1 wild type or mutants, pcDNA3.1(-) as negative control,
along with pCMV-β-gal as the control for transfection efﬁciency. At
48 h post-transfection, cells were harvested in lysis buffer, and
luciferase assays were performed using the Luciferase assay
system (Promega). The β-galactosidase activities were used to
normalize the luciferase activities. Three independent transfection
experiments were performed.
Western blotting
HEK293T or HT1080 cells lysates were mixed with 6 SDS
loading buffer, and then boiled for 20 min at 100 1C. The protein
samples were resolved by SDS-PAGE and transferred onto poly-
vinylidene diﬂuoride membranes (PVDF) (GE Healthcare). The
membranes were blocked in 5% non-fat milk (in PBS) for 60 min
at room temperature, and incubated ﬁrst with primary antibodies
for 90 min at room temperature or overnight at 4 1C and then with
horseradish peroxidase-conjugated secondary antibodies for
60 min at room temperature. After the membranes treated with
the enhanced chemiluminescence reagents (Millipore), the speci-
ﬁc protein signals were detected by exposure to X-ray ﬁlms.
Fig. 6. Wild type Bel1 is able to rescue the production of PFV containing the Bel1
R199H200 mutant. (A) HEK293T cells were cotransfected with 0.5 mg infectious clone
PFV Bel1 M199 or PFV Bel1 WT, indicated amounts of wild type Bel1 expression
plasmid or empty vector. pEGFP-N1 was cotransfected to monitor toxicity and
transfection efﬁciency. After 48 h, whole cell lysates were subjected to Western
blotting and probed with indicated antibodies. (B) Virus titer in supernatants
(PFVL-Supernatants) was measured by infecting PFVL. Results shown are the
average of three independent experiments.
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Electrophoretic mobility shift assay (EMSA)
EMSA was carried out using DIG Gel Shift Kit (Roche). Probes
for PFV LTR (LTR sense: 5′-GCAGCTTTTTATCCACTAGGGA-
TAATGTTTTAAGGAATACTATAGTAATAGATTGATAGTTTTAACAATGA
TAGA-3′) and IP (IP sense: 5′-AGGCCACTGGTTGCGGAAGAAA-
GATTG-3′) (Regad et al., 2001) were synthesized and annealed
with the complementary strand. EGFP-GST fusion proteins (EGFP-
GST, EGFP-Bel1-GST Bel1 wild type or mutants) were expressed in
E. coli strain BL21 and puriﬁed by glutathione sepharose beads
(Amersham Biosciences). Protein concentrations were determined
by Bradford assay. EGFP-GST fusion proteins (0.1 μg) were incu-
bated with digoxigenin (DIG)-labeled probes in binding buffer for
20 min at room temperature. Prior to incubation, 125 molar
excess unlabeled probes were used as competitor. The DNA-
protein complexes were resolved by 6% non-denaturing polyacry-
lamide gel and probed with anti-DIG-AP antibody.
Viruses
HEK293T cells were transfected with pCHFV DNA clones along
with indicated plasmids. At 48 h post-transfection, supernatants
were collected. Cell lysates were subjected to Western blotting to
examine the viral proteins expression. The indicator cell line PFVL
was used to monitor virus titer. Viral supernatants or 1/10 virus
producing cells were incubated or co-cultured with PFVL, respec-
tively. At 24 h post-infection, PFVL cells were washed twice with
1 PBS and changed with fresh medium. After incubation for
another 24 h, luciferase assay was performed. Three independent
transfection experiments were performed.
For virus production in HT1080 cells, transfection was carried
out similar to HEK293T cells. At 72 h post-transfection, the Gag
proteins were visualized by indirect immunoﬂuorescence using
anti-Gag serum. Cellular nuclei were stained with 0.2 μg/ml DAPI.
The syncytium was directly observed with Olympus IX71 ﬂuores-
cence microscope. Viral proteins were detected by Western
blotting.
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